Synopsis: Zydus Lifesciences Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Baddi manufacturing facility in Himachal Pradesh. The inspection, conducted between August 4 and August 13, 2025, has been classified as “Voluntary Action Indicated” (VAI), marking its successful closure without any […]
